Printer Friendly

WATSON PHARMACEUTICALS ANNOUNCES COMMON STOCK OFFERING

 CORONA, Calif., Nov. 12 /PRNewswire/ -- Watson Pharmaceuticals Inc. (NASDAQ: WATS) today announced the public offering of 2,000,000 shares of common stock at $29 per share. Of the shares offered, 765,000 shares are being sold by the company and 1,235,000 are being sold by selling stockholders. In addition, the company has granted the underwriters a 30-day option to purchase up to 300,000 additional shares to cover over- allotments, if any.
 The shares will be offered only by means of a prospectus by an underwriting group managed by Bear Stearns & Co. Inc., Donaldson, Lufkin & Jenrette Securities Corp. and Furman Selz Inc. The net proceeds from the offering will be used for the expansion and acquisition of facilities, equipment purchases, and for working capital and other general corporate purposes.
 Watson Pharmaceuticals manufactures and distributes off-patent pharmaceuticals and is developing advanced drug delivery systems designed to enhance the therapeutic benefits of pharmaceutical compounds.
 -0- 11/15/93
 /CONTACT: Doug Sherk or Stuart Brunet, 415-296-7383, or Lisa Carlton or Jill Moskowitz, 212-850-5600, all of Morgen-Walke for Watson Pharmaceuticals/
 (WATS)


CO: Watson Pharmaceuticals Inc. ST: California IN: MTC SU: OFR

TM-RB -- SF006 -- 3745 11/12/93 14:02 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 12, 1993
Words:199
Previous Article:INCYTE CLOSES IPO: UNDERWRITER EXERCISES OVER-ALLOTMENT
Next Article:ACME-CLEVELAND REPORTS BETTER FISCAL YEAR RESULTS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters